22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Update

22nd Century Group, Inc. (NASDAQ:XXII) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 91,500 shares, a growth of 1,933.3% from the December 15th total of 4,500 shares. Based on an average daily volume of 109,400 shares, the short-interest ratio is presently 0.8 days. Currently, 19.5% of the company’s shares are short sold.

Institutional Investors Weigh In On 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP bought a new position in shares of 22nd Century Group, Inc. (NASDAQ:XXII) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Tuesday, December 31st.

22nd Century Group Stock Up 22.7 %

XXII stock traded up $1.11 during mid-day trading on Monday, hitting $6.00. The stock had a trading volume of 23,260,225 shares, compared to its average volume of 3,640,817. 22nd Century Group has a 1-year low of $3.90 and a 1-year high of $581.85. The company has a fifty day moving average of $9.91 and a 200 day moving average of $41.98. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. The stock has a market capitalization of $3.32 million, a price-to-earnings ratio of -0.27 and a beta of 1.59.

22nd Century Group (NASDAQ:XXII) last posted its earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share (EPS) for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The business had revenue of $5.95 million during the quarter.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.